Data
Click on Protocol Number of interest to view study-related documentation or download data files.
(DTMC data files are under development.)
Division | Study Number | Title Sort ascending | Investigator(s) | Release Date |
---|---|---|---|---|
DTMC | NIDA-MDS-0003 | Phase I, Double-Blind, Placebo-Controlled Assessment Of Potential Interactions Between Intravenous Cocaine And Ethanol And Oral Disulfiram | John D. Roache, Ph.D. | Dec 21, 2017 |
DTMC | NIDA-CSP-1025 | Phase 2, Double-Blind, Placebo-Controlled Trial Of Topiramate For The Treatment Of Methamphetamine Dependence | Bankole Johnson, DSc., M.D., Ph.D. | Sep 02, 2015 |
DTMC | NIDA-CTO-0012 | Phase 2, Double-Blind, Placebo-Controlled Trial Of Tiagabine For The Treatment Of Cocaine Dependence | Eugene Somoza, M.D. | Jan 15, 2019 |
DTMC | NIDA-CSP-1022 | Phase 2, Double-Blind, Placebo-Controlled Trial Of Selegiline Transdermal System (STS) As An Aid For Smoking Cessation | Elbert D. Glover, PhD, FASHA, FAAHB, FRIPH | May 07, 2018 |
DTMC | NIDA-CTO-0001 | Phase 2, Double-Blind, Placebo-Controlled Trial Of Reserpine For The Treatment Of Cocaine Dependence | Eugene Somoza, M.D. | Dec 04, 2014 |
DTMC | NIDA-MDS-0004 | Phase 2, Double-Blind, Placebo-Controlled Trial Of Modafinil For The Treatment Of Cocaine Dependence | Domenic Ciraulo, M.D. | Sep 02, 2015 |
DTMC | NIDA-CSP-1026 | Phase 2, Double-Blind, Placebo-Controlled Trial Of Modafinil For Methamphetamine Dependence | Ahmed Elkashef, M.D. | Sep 02, 2015 |
DTMC | NIDA-CTO-0007 | Phase 2, Double-Blind, Placebo-Controlled Trial Of Cabergoline For The Treatment Of Cocaine Dependence | Steven Shoptaw, Ph.D., Thomas F. Newton, M.D. | Dec 21, 2017 |
DTMC | NIDA-MDS-0007 | Phase 2, Double-Blind, Placebo-Controlled Trial Of Bupropion For Methamphetamine Dependence | Ann Anderson, M.D. | Dec 04, 2014 |
DTMC | NIDA-CTO-0008 | Phase 2, Double-Blind Placebo-Controlled Trial Of Bupropion for the Treatment of Methamphetamine Dependence | Richard Rawson, Ph.D. | May 07, 2018 |